Example: Heart Attack

Search clinical trials for: Insulin glulisine

Total 116 results

NCT00969592

Completed

Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers

Conditions: Diabetes
NCT01159353

Completed

Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart

Conditions: Type 2 Diabetes Mellitus
NCT01436045

Completed

Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.

Conditions: Alzheimer's Disease
NCT00913497

Completed

The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children

Conditions: Type 1 Diabetes Mellitus
NCT00397553

Completed

Insulin Glulisine, Diabetes Mellitus Type 1

Conditions: Diabetes Mellitus, Type 1
NCT01202474

Completed

Apidra Children & Adolescents Study

Conditions: Diabetes Mellitus, Type 1
NCT00290979

Completed

Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 1
NCT01662921

Completed

Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes

Conditions: Diabetes During Pregnancy
NCT02276196

Completed

Effect of LIXIsenatide on the Renal System

Conditions: Diabetic Kidney Disease; Diabetic Nephropathy; Diabetes Mellitus; Glucagon-Like Peptide 1
NCT01678235

Completed

Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT00562133

Completed

Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes

Conditions: Diabetes Mellitus
NCT01203111

Completed

Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs

Conditions: Diabetes Mellitus, Type 2
NCT00964574

Completed

Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 1
NCT00528918

Completed

Comparison of Apidra to Regular Insulin in Hospitalized Patients

Conditions: Diabetes Mellitus, Type II
NCT00310297

Completed

Insulin Glulisine in Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT00311077

Completed

Insulin Glulisine in Healthy Lean and Obese Subjects

Conditions: Diabetes Mellitus
NCT00297583

Completed

Insulin Glulisine in Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT00526513

Completed

Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus

Conditions: Diabetes Mellitus
NCT02503501

Terminated

Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease

Conditions: Mild Cognitive Impairment; Alzheimer's Disease (AD)
NCT00272012

Completed

OPAL - Insulin Glulisine, Diabetes Mellitus

Conditions: Diabetes Mellitus Type 2
NCT01204593

Completed

baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 1
NCT00135083

Completed

Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT00290927

Completed

Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT00135941

Completed

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

Conditions: Diabetes Mellitus
NCT01079364

Terminated

Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting

Conditions: Diabetes Mellitus, Type 2